Cas:1289585-19-8 (S)-1-(2-Chloro-6-fluoro-benzyl)-pyrrolidin-3-ol manufacturer & supplier

We serve Chemical Name:(S)-1-(2-Chloro-6-fluoro-benzyl)-pyrrolidin-3-ol CAS:1289585-19-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

(S)-1-(2-Chloro-6-fluoro-benzyl)-pyrrolidin-3-ol

Chemical Name:(S)-1-(2-Chloro-6-fluoro-benzyl)-pyrrolidin-3-ol
CAS.NO:1289585-19-8
Synonyms:(S)-1-(2-Chloro-6-fluoro-benzyl)-pyrrolidin-3-ol
Molecular Formula:C11H13ClFNO
Molecular Weight:229.6784232
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:
Exact Mass:
LogP:

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like (S)-1-(2-Chloro-6-fluoro-benzyl)-pyrrolidin-3-ol chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(S)-1-(2-Chloro-6-fluoro-benzyl)-pyrrolidin-3-ol physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(S)-1-(2-Chloro-6-fluoro-benzyl)-pyrrolidin-3-ol Use and application,(S)-1-(2-Chloro-6-fluoro-benzyl)-pyrrolidin-3-ol technical grade,usp/ep/jp grade.


Related News: CDMOs closely work with companies who want to pursue upcoming innovations in medicines, help cope with shortcomings of internal lab-to-manufacturing scale-up. 1-(phenylsulfonyl)-1h-indole-3-carbaldehyde manufacturers The Institute for Clinical and Economic Review (ICER) on Friday released its report examining the cost-effectiveness of Soliris, also known as eculizumab, as well as up-and-comer efgartigimod for patients with the myasthenia gravis. 1-(6-Methyl-2-pyridinyl)-2-[1,2,4]triazolo[1,5-a]pyridine-6-yl-ethanone suppliers “This announcement reflects another important regulatory milestone in the development of this medicine,” said Roy Baynes, senior vice president and head of global clinical development, chief medical officer, Merck Research Laboratories. 5-bromopyrrolo[2,1-f][1,2,4]triazin-4-amine vendor & factory.